Whilst price cut cards can help relieve the burden of high drug costs while in the temporary, they don't deal with the systemic concerns driving up prescription prices from the U.S. Broader policy changes could deal with the root brings about of climbing drug costs, such as insufficient transparency in pricing along with the role of intermediaries